Advanced Proton Pump Inhibitor Research
Nexium 20 AstraZeneca is a pharmaceutical-grade proton pump inhibitor containing esomeprazole magnesium 20mg per capsule. As the S-enantiomer of omeprazole, esomeprazole represents a refined approach to studying gastric acid suppression mechanisms in laboratory environments. This AstraZeneca-manufactured formulation provides researchers with access to authentic pharmaceutical preparations for investigating proton pump biology and acid-related gastric pathways.
Research laboratories examining gastrointestinal physiology often require standardised pharmaceutical compounds to investigate cellular mechanisms underlying acid secretion. Stroid UK Shop ensures consistent access to pharmaceutical-grade materials essential for advancing scientific understanding of gastric acid regulation and related metabolic processes.
Laboratory Investigation Applications
Esomeprazole research applications encompass cellular studies of H+/K+-ATPase enzyme inhibition and gastric parietal cell function analysis. Laboratory protocols frequently examine the compound’s mechanism of action through irreversible binding to the proton pump’s cysteine residues, creating opportunities to study enzyme regeneration kinetics and cellular recovery patterns in controlled research environments.
Advanced research methodologies investigate esomeprazole’s pharmacokinetic properties, including cytochrome P450 metabolic pathways and bioavailability characteristics. Scientists examining esomeprazole research applications often compare its selective inhibition profile against other pharmaceutical compounds, contributing valuable data to gastroenterology research initiatives.
Contemporary laboratory investigations extend beyond basic acid suppression studies to examine esomeprazole’s potential interactions with selective androgen receptor modulators and peptide research compounds, particularly regarding absorption enhancement and bioavailability modification in experimental protocols.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Esomeprazole magnesium |
| Strength | 20mg per capsule |
| Manufacturer | AstraZeneca |
| Form | Enteric-coated capsules |
| CAS Number | 217087-09-7 |
| Molecular Formula | C34H36MgN6O6S2 |
| Storage | Room temperature, dry conditions |
Research Compliance Information
Nexium 20 AstraZeneca is intended strictly for in-vitro laboratory research applications and scientific investigation purposes only. This pharmaceutical preparation is not approved for human consumption, therapeutic use, or any clinical applications outside authorised research protocols. Researchers must maintain appropriate laboratory safety standards and institutional review board approval when conducting studies involving this compound. All experimental work should comply with relevant laboratory guidelines and regulatory frameworks governing pharmaceutical research materials.
